OraSure Technologies (NASDAQ:OSUR)
Historical Stock Chart
From Oct 2019 to Oct 2024
OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that Ronald H.
Spair, Chief Operating Officer and Chief Financial Officer, will speak
to the investment community at the Cowen & Co. Health Care Conference in
Boston, Massachusetts. The conference will be simultaneously webcast
over the Internet.
Mr. Spair is scheduled to speak on March 20, 2008, at approximately
10:15 am Eastern Time (7:15 am Pacific Time). Interested investors can
access the live webcast of the presentation by going to OraSure
Technologies’ web site, www.orasure.com,
and clicking on the Investor Info link. A replay of the webcast will be
available on OraSure Technologies’ web site
for seven days. Alternatively, you can access the live webcast of the
presentation via the following link http://www.cowen.com.
About OraSure Technologies
OraSure Technologies develops, manufactures and markets oral fluid
specimen collection devices using proprietary oral fluid technologies,
diagnostic products including immunoassays and other in vitro
diagnostic tests, and other medical devices. These products are sold in
the United States as well as internationally to various clinical
laboratories, hospitals, clinics, community-based organizations and
other public health organizations, distributors, government agencies,
physicians’ offices, and commercial and
industrial entities.
OraSure Technologies is the leading supplier of oral-fluid collection
devices and in vitro diagnostic assays to the employment,
criminal justice, drug treatment, life insurance and public health
markets for the detection of abused drugs and the antibodies to HIV.
Based in Bethlehem, Pa., the company develops, manufactures and markets
oral specimen collection devices, in vitro diagnostic tests, and
other medical devices. For more information on the Company, please go to www.orasure.com.